AEON Biopharma, Inc.
Developing therapeutic neurotoxins for medical conditions like migraines and cervical dystonia.
AEON | NYSE
Overview
Corporate Details
- ISIN(s):
- US00775E1029 (+2 more)
- LEI:
- Country:
- United States of America
- Address:
- 5 PARK PLAZA, 92614 IRVINE
- Website:
- https://www.aeonbiopharma.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
AEON Biopharma, Inc. is a clinical-stage biopharmaceutical company focused on the research, development, and commercialization of therapeutic neurotoxins. The company is dedicated to developing its proprietary botulinum toxin complex, ABP-450 (prabotulinumtoxinA), for the treatment of debilitating medical conditions. AEON Biopharma concentrates exclusively on therapeutic applications, targeting an array of nervous system-related and neuromuscular disorders, such as migraines and cervical dystonia, to address unmet patient needs.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all AEON Biopharma, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for AEON Biopharma, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for AEON Biopharma, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
